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Results: Complete data sets were available for 58 defibrillators; 3 had been replaced at 
follow-up. The mean (*SD) time difference between defibrillators and the atomic ckxk 
after 3 months was 1.50 + 1.66 min (range 0 - 10 min). For each defibrillator model, the 
mean time difference after 3 months was 0.71 f 0.63 min (Lifepack 9, N = 34), 1.60 + 
1.34 min (Lifepack 10, N = 5), 2.17 * 1.33 min (Heartstream, N = 6), 3.33 * 0.52 min 
(Lifepack 12, N = 6), 4.25 * 4.03 min (HP Codemaster, N = 4), 2.00 f 1.41 min (Zoll M, 
N=2) and 1 .oO min (Lifepack 7, N=l). The Lifepack 9 defibrillator clocks had significantly 
less time change over 3 months than Heartstream, Lifepack 12 and HP Codemaster 
defibrillator clocks (P < .0003). 
Conclusion : Defibrillator clocks are unable to maintain accurate time over 3 months. 
Without extra measures defibrillator clocks are too inaccurate to be used to assess col- 
lapse-to-first shock time interval. 
decreased from 77r20% to 30+37% in Gr 1 (p=O.O03) and from 6&29% to 13*19% I” 
Gr 2 (p=0.0001). Stress perfusion defects extension in the 2nd vessel territory decreased 
from 48+17% to 20223% in Gr 1 (p=O.O05) and from 55+16% to 21~21% in Gr 2 
(p=O.O004). Severity score decreased from 2.62kO.75 to 1.53+0.70 in Gr 1 (p=O.O02) and 
from 2.174.55 to 1.17+0.24 in Gr 2 (p=O.OOOl) for the LAD territory. It decreased from 
1.96eO.38 to 1.35t0.49 in Gr 1 (p=O.O02) and from 2.02+0.50 to 1.31+0.53 in Gr 2 
(p=O.OOOS) for the 2nd vessel territory. No between-group difference at 12 months was 
significant. 
Conclusion: In patients with two-vessel CAD, at 12 months after MIDCAB of the LAD, 
myocardial pedusion shows a similar sustained improvement both in the LAD and in the 
2nd vessel territories, irrespective of revascularization by PTCA. 
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1028-98 Is Endoaneurysmorrhaphy Superior to Linear Suture for 
Left Ventricular Aneurysm Repair? 
Andrea Colli. Flavio Cocconcelli Cocconcelli, Marco Barchetii, Marco Golinelli. Nasser 
Asgharnejad Fahim, Alessandro Navazio. Roberto Parravicini, Tiziano Gherli, Villa 
Salus, Reggio Emilia, Italy. University of Parma, Parma, Italy 
Objectives: Endoaneurismorraphy (EA) has been proposed as a more physiologic repair 
of postinfarction left ventncular aneurysm (LVA) than is linear repair.The aim of the 
present study was to evaluate early and late results of 2 different surgical techniques for 
the LVA repair(EA versus linear closure [LC]) 
Methods Between November 1993 and November 2001, 112 patients(pts),gO 
males(80%),underwent surgical repair for LVA.EA (Group A) was employed in 69 
pts(61.6%) and LC(Group B) in 44 patients(38.4%).Clinical outcomes and echocardio- 
graphic measurements of Group A were compared with those in Group 8. 
Results Mean follow-up time is 44.5 * 33.1 months.Preoperatively NYHA class, left van- 
tricular (LV) ejection fraction (EF) and LV end-diastolic diameter were similar.Early over- 
all monality rate was 4.4%.Early postoperative increase in LVEF was greater after 
EA(4.6 * 7.3 vs 0.6+6.l,p=O.O15).Functional status improvement was significant for all 
the pts despite the different repair technique used(p=O.OOOl)as perhaps the LVEF 
increase (p=O.O002). There were no differences between the 2 groups for the NYHA 
class(change in NYHA class -1.3iO.9 in Group A and -1.2+0.8 in Group B,p=0.479)and 
for the LVEF(37.2+8.7 vs 37.9+9.3,p=O.721 .The actuarial survival rate at 5 years were 
78+7% for Group A and 85*7% for Group B (p=0.479).Comparison with LogRank test 
revealed no significant difference in cardiac death between 2 groups (p=O.l48).A preop- 
erative NYHA class >ll(p=O.O18) and a LVEF <35%(p=O.O05) were associated with a 
higher incidence of early and late mortality. 
Conclusions LVA repair is an important therapeutic intervention.Both EA and LC 
appear extremely safe and efficacy showing a low operative mortality.Long term outcome 
resulted substantially Similar for both repair methods.The surgical “combined” approach 
permits a better outcome for pts undergoing LVR 
POSTER SESSION 
1028 Combined Procedure Outcomes in 
Coronary Artery Bypass Patients 
Sunday, March 30, 2003, Noon-2:00 p.m. 
McCormick Place, Hall A 
Presentation Hour: Noon-l:00 p.m. 
1028-96 Higher Mortality in Patients With Patent Stented Arteries 
Undergoing Coronary Artery Bypass Surgery 
Niranian Seshadri, Mehdi Shishehbor, Naveen Acharya, Marc n. Gillinov, Eugene H. 
Blackstone, Raymond Q. Migrino, Sasan Ghaffari, The Cleveland Clinic Foundation, 
Cleveland, OH 
Aim: Current surgical practice is to bypass a previously stented artery even if it is patent. 
Does bypassing a patent stented artery affect outcome? We sought to compare out- 
comas of patients with patent stents (<50% stenosis) with those with in-stent restenosis 
(z-50% stenosis) undergoing coronary artery bypass grafting (CABG) to the stented arter- 
ies. 
Methods: From 1995 through 2001, 359 patients had coronary stents and CABG at our 
institution. Of these, 162 had patent stents and 197 had stems with in-stent restenosis 
that were bypassed. Patients in the 2 groups were similar with respect to age. left ventric- 
ular function, extent of coronary disease, time from stent to CABG and prevalence of dia- 
betes, smoking, hypertension and renal insufficiency. Survival data was determined 
using Social Security Death Index. Results: At a mean follow up of 42218 months, there 
were 18 deaths in patients with patent stems and 11 patients with in-stem restenosis 
undergoing CABG. Kaplan-Meier analysis is shown in the figure (p=O.O5). 
Conclusions: 
Patients with patent stents undergoing CABG to the stented vessel had a higher mortality 
than did similar patients with in-stent restenosis. 
1028-97 Minimally Invasive Coronary Bypass Grafting of the Left 
Anterior Descending Coronary Artery Improves 
Myocardial Perfusion in the Nonrevascularized Second 
Vessel Territory in Two-Vessel Coronary Artery Disease 
Oberdan Parodi, Renata De Maria, Albert0 Repossinl, Wafer Dabdoob, Ida Venw, 
Albert0 Bestetti. Angelo Del Sole, Emmanuela Devote, Marina Parolini, Paolo Biglioli, 
CNR Clinical Physiology Institute, Milan, Italy, Humanitas Gavaueni, Bergamo, Italy 
Background: Although coronary bypass grafting and coronary angioplasty (PTCA) are 
equally effective to achieve target vessel revascularization in multivessel coronary artery 
disease (CAD), little is known on the long-term impact of minimally invasive coronary 
bypass grafting (MIDCAB) on myocardial perfusion in two-vessel CAD. 
Methods: Thirty-one patients (age 63+10 yrs) with two-vessel CAD of the left anterior 
descending coronary artery (LAD) and the left circumflex (n=lE) or right coronary artery 
(n=13) were studied by stress/rest perfusion SPECT. Perfusion was scored in a 16.seg- 
ment model from 1 (normal) to 4 (absent uptake); percent extension and severity of per- 
fusion defects were evaluated in the territory of the LAD and of the Stenotic 2nd vessel. 
Quality of life was assessed by the SF-36 questionnaire. All patients underwent MIDCAB 
of the LAD, alone in 12 cases (Gr I), or coupled to PTCA and stenting of the 2nd vessel 
in 19 (Gr 2). Clinical follow-up, SF-36 and SPECT were repeated 12 months after sur- 
gsly- 
Results: Baseline variables were not different in the 2 groups. During 12month follow- 
up, no cardiac events occurred and significant improvement was observed versus base- 
line. SF-36 score increased from 102+23 to 131i12 in Gr 1 (p= 0.004) and from 93+21 to 
13lr13 in Gr 2 (p=O.OOOl). Stress perfusion defects extension in the LAD territory 
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1048-89 Multiple Complex Unstable Plaques Associated With 
Systemic Inflammation and Adverse Cardiovascular 
Outcomes 
Harish R. Chandra, William W. O’Neill. James A. Goldstein, William Beaumont Hospital, 
Royal Oak, Ml 
Background: Recent observations demonstrate that patients with acute coronary syn- 
drome (ACS) often harbor multiple unstable plaques, consistent with the concept that 
destabilizing processes such as inflammation may exert adverse influence throughout 
the coronary bed. This study was designed to determlne whether there is a relationship 
between the presence and magnitude of systemic inflammation, the number of unstable 
complex lesions (CL) and adverse cardiovascular events. Methods: In 283 patients with 
ACS undergoing coronary angiography, we analyzed the asscciation between the num- 
ber of CL, systemic marker of inflammation (high sensitivity C-reactive protein, CRP) and 
major adverse cardiovascular events (MACE) at one year (cardiac death, non-fatal Ml 
and revascularization). Univariate and multwariate analysis were performed. Results: A 
single CL was present in 32% of pts, multiple CL were idenbfied in 23% and no CL were 
documented in 45% of cases. There was a direct association between increasing num- 
ber of CL and increments in systemic marker of inflammation (in pts. with none, one and 
multiple CL, CRP= 0.22, 0.53 and 1.85 mg/d, pc0.0001). On multivariate analysis, CRP 
was indeoendentlv associated with the oresence of multi&s comolex coronarv lesions 
(p-zO.000;). At on, year follow up, major adverse cardiac eients were reported & 24% of 
cases (death in 5.7%. Ml in 3.9%. and revascularization in 17.7%). On multivariate anal- -\ 
ysis. only the presence of multiple CL (HR 2.88, p=O.O007) and history of congestive 
heart failure (HR 2.57, p=O.O37) were independent predictors of MACE at 1 year 
Conclusions: These findings demonstrate a strong association between the presence of 
multiple complex unstable plaques, the magnitude of systemic inflammation and adverse 
clinical outcome. 
